Hester Biosciences (BOM:524669) Short Interest


BOM:524669 Hester Biosciences Ltd BOM:524669
73 GF Score
Price ₹2,193.45
GF Value ₹1,885.73
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Hester Biosciences Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:524669 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hester Biosciences's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hester Biosciences Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hester Biosciences's Short Interest distribution charts can be found below:

* The bar in red indicates where Hester Biosciences's Short Interest falls into.


BOM:524669
73GF Score
Hester Biosciences Ltd BOM:524669
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hester Biosciences (BOM:524669) Overvalued in 2026?

Based on GuruFocus' analysis, Hester Biosciences stock appears to be overvalued. The current stock price of ₹2,193.45 is trading 16.3% above its estimated GF Value™ of ₹1,885.73. GuruFocus considers Hester Biosciences to be Modestly Overvalued.

Key valuation signals for BOM:524669:

  • Short Interest:
  • GF Value™: ₹1,885.73 vs. price of ₹2,193.45 (16.3% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the BOM:524669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hester Biosciences Business Description

Other Exchanges HESTERBIO:India
Address Village Meda - Adraj, Taluka Kadi, District Mehsana, Mehsana, GJ, IND, 384441
Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.
73GF Score

Get the complete analysis for BOM:524669

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,193.45
Price
₹1,885.73
GF Value